Optimization of amino acid-stabilized erythropoietin parenteral formulation: In vitro and in vivo assessment
The aim of this study was to optimize the formulation of erythropoietin (EPO) using amino acids instead of human serum albumin (HSA) and to evaluate its in vivo stability in order to avoid the risk of viral contamination and antigenicity. Different EPO formulations were developed in such a way as to...
Main Authors: | Fayed Bahgat E., Tawfik Abdulkader F., Yassin Alaa Eldeen B. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-03-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.1515/acph-2016-0007 |
Similar Items
-
Detection of antibodies to erythropoietin-based drugs: is it possible to create the universal test system?
by: A. M. Kudryashova, et al.
Published: (2021-06-01) -
The Role of Erythropoietin in Preventing Anemia in the Premature Neonate
by: Oana Cristina Costescu, et al.
Published: (2023-11-01) -
Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
by: Anna Thawanny Gadelha Moura, et al. -
Stability of erythropoietin repackaging in polypropylene syringes for clinical use
by: Angela Marsili, et al.
Published: (2017-02-01) -
Bisalbuminemia: A Pathologist’s Insight of an Uncommon Phenomenon
by: Gargi Kapatia, et al.
Published: (2021-06-01)